1. Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial. Issue 4 (April 2021) Authors: Walgaard, Christa; Jacobs, Bart C; Lingsma, Hester F; Steyerberg, Ewout W; van den Berg, Bianca; Doets, Alexandra Y; Leonhard, Sonja E; Verboon, Christine; Huizinga, Ruth; Drenthen, Judith; Arends, Samuel; Budde, Ilona Kleine; Kleyweg, Ruud P; Kuitwaard, Krista; van der Meulen, Marjon F G; Samijn... Journal: Lancet neurology Issue: Volume 20:Issue 4(2021) Page Start: 275 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗